KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Retained Earnings (2020 - 2025)

Historic Retained Earnings for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to -$3.3 billion.

  • Oscar Health's Retained Earnings fell 1554.22% to -$3.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.3 billion, marking a year-over-year decrease of 1554.22%. This contributed to the annual value of -$3.3 billion for FY2025, which is 1554.22% down from last year.
  • According to the latest figures from Q4 2025, Oscar Health's Retained Earnings is -$3.3 billion, which was down 1554.22% from -$2.9 billion recorded in Q3 2025.
  • Oscar Health's 5-year Retained Earnings high stood at -$1.5 billion for Q1 2021, and its period low was -$3.3 billion during Q4 2025.
  • For the 5-year period, Oscar Health's Retained Earnings averaged around -$2.5 billion, with its median value being -$2.6 billion (2023).
  • In the last 5 years, Oscar Health's Retained Earnings crashed by 4012.36% in 2021 and then surged by 456.91% in 2025.
  • Over the past 5 years, Oscar Health's Retained Earnings (Quarter) stood at -$2.0 billion in 2021, then plummeted by 30.32% to -$2.6 billion in 2022, then decreased by 10.39% to -$2.9 billion in 2023, then increased by 0.88% to -$2.9 billion in 2024, then fell by 15.54% to -$3.3 billion in 2025.
  • Its Retained Earnings stands at -$3.3 billion for Q4 2025, versus -$2.9 billion for Q3 2025 and -$2.8 billion for Q2 2025.